Buckle will head the Group’s two subsidiaries: InGen, a supplier of high-performing reagents combined with platform analysis to roughly 750 customers in Europe; and InGen BioSciences, the Group’s r&d facility focused on bringing innovative tests to market. The Group reported sales of €20m in 2009.
Buckle joins the firm from Applied Biosystems, now part of Life Technologies, where she was business director for global strategic accounts, worldwide for five years.
Prior to this, Buckle worked for six years at Ciphergen Biosystems, a developer of protein chip systems, first as regional director for Southern Europe, Belgium and Switzerland and later as head of Business Development Diagnostic Europe. Buckle also worked for nine years for Amersham Pharmacia Biotech (now part of GE).
‘I see many opportunities that will both increase our distribution panel and continue to supply our R&D funnel with new products that contribute to clinical and diagnostic applications,’ said Buckle.
InGen BioSciences Group is located in Chilly-Mazarin, near Paris, and employs 65 people.
